2016AddictionOpen access

Intranasal naloxone soon to become part of evolving clinical practice around opioid overdose prevention

Paul Dietze, Kate Cantwell

Open full text 8 citations

Abstract

Commentary to: Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?

Open-access reader

About this research paper

What this paper is about

Commentary to: Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?

Why it matters

OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Commentary to: Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?

Key concepts: Opioid overdose, (+)-Naloxone, Opioid, Medicine, Opioid epidemic, Opioid-Related Disorders, Nasal administration, Drug overdose

Related papers

Back to paper searchBrowse research topicsOriginal source
Intranasal naloxone soon to become part of evolving clinical practice around opioid overdose prevention — Research Paper | ScholarLens